Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q3 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin (NUS) is witnessing continued macroeconomic hurdles and an inflationary environment. The company is also battling unfavorable currency movements.

Nu Skin (NUS) Down More Than 25% in 3 Months: Here's Why

Nu Skin Enterprises had been impacted by COVID-19 initially and tough macro-environment recently, leading to a decline in sales and lowered guidance for 2023. The company reported resilient Q2 earnings with sustained gross margins and in line EPS supported by strong growth in China. Despite the challenges, the valuation appears attractive at just 8.7x Fwd PE and a forward dividend yield of 6.7%.

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Nu Skin's (NUS) margins have been contracting year over year for a while now. The company is also battling unfavorable currency headwinds.

Nu Skin (NUS) Appears Dull on High Cost & Currency Headwinds

Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consumer spending and customer acquisition.

Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world's No. 1 brand for beauty device systems for six consecutive years by Euromonitor International Ltd., which publishes the world's most comprehensive market research on the skincare industry. Nu Skin is the world's best-selling beauty device system brand based on Euromonitor custom research and methodology conducted April to June of 2023.* “We're continuing our indust.

Nu Skin Ranked the World's #1 Brand for Beauty Device Systems for Six Consecutive Years

Nu Skin (NUS) reports sequential improvements in Q2 results, driven by the Mainland China and Rhyz segments. However, macro-economic factors pose challenges in the key markets.

Nu Skin (NUS) Lowers 2023 Guidance Despite Q2 Earnings Beat

NU Skin Enterprises, Inc. (NYSE:NUS ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Scott Pond - VP, IR Ryan Napierski - President, CEO & Director Connie Tang - EVP & Chief Global Growth & Customer Experience Officer James Thomas - Interim CFO Conference Call Participants Chasen Bender - Citi Blake Anderson - Jefferies Christopher Armes - Stifel Linda Bolton-Weiser - D.A. Davidson Operator Good day, ladies and gentlemen.

NU Skin Enterprises, Inc. (NUS) Q2 2023 Earnings Call Transcript

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.77 per share a year ago.

Nu Skin Enterprises (NUS) Surpasses Q2 Earnings Estimates

PROVO, Utah , Aug. 1, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second quarter 2023 results in line with expectations. Executive Summary Q2 2023 vs.

Nu Skin Enterprises Reports Second Quarter 2023 Financial Results

PROVO, Utah , Aug. 1, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.39 per share, which will be paid on Sept. 6, 2023, to shareholders of record on Aug. 25, 2023.

Nu Skin Enterprises Announces Quarterly Dividend

PROVO, Utah , Aug. 1, 2023 /PRNewswire/ -- Rhyz Inc., a subsidiary of Nu Skin Enterprises Inc. (NYSE: NUS), today announced the acquisition of BeautyBio, a clean and clinically proven skincare and beauty device brand. Rhyz adds this omnichannel beauty brand to its existing synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

Rhyz Inc. Acquires Skincare and Beauty Device Company BeautyBio

PROVO, Utah , July 27, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of James D. Thomas as executive vice president and chief financial officer.

Nu Skin Enterprises Appoints James D. Thomas as Chief Financial Officer

Nu Skin's (NUS) second-quarter 2023 performance will likely reflect macroeconomic challenges like rising global inflation. Also, unfavorable currency rates are a concern.

Nu Skin (NUS) Gears Up for Q2 Earnings: What's in Store?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Nu Skin Enterprises (NUS) Right Now?

PROVO, Utah, July 10, 2023 (GLOBE NEWSWIRE) -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release second quarter 2023 results after the market closes on Tuesday, Aug. 1. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.

Nu Skin Enterprises to Announce Second Quarter 2023 Financial Results

Demand is currently weak due to lower consumer purchasing power as a consequence of inflation. Strong inflationary pressures are also negatively impacting profit margins, which remain depressed. The company has recently launched three new products, including the Beauty Focus Collagen+ skin care supplement, the ageLOC Meta nutritional supplement, and ageLOC LumiSpa iO.

Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks

The company continues its commitment to help children worldwide with hospital kits and hygiene products, as well as a donation to Primary Children's Hospital in Utah County from its nonprofit foundation The company continues its commitment to help children worldwide with hospital kits and hygiene products, as well as a donation to Primary Children's Hospital in Utah County from its nonprofit foundation

Nu Skin Celebrates 20th Annual Force for Good Day with Global Day of Service

Nu Skin's (NUS) first-quarter 2023 results reflect difficult year-over-year comparisons and macroeconomic hurdles. However, a focus on the Nu Vision 2025 strategy has been working well.

Nu Skin (NUS) Q1 Earnings & Revenues Top Estimates, Dip Y/Y

NU Skin Enterprises, Inc. (NYSE:NUS ) Q1 2023 Earnings Conference Call May 3, 2023 5:00 PM ET Company Participants Scott Pond - VP, IR Ryan Napierski - President, CEO & Director Connie Tang - EVP & Chief Global Growth & Customer Experience Officer James Thomas - Interim CFO Conference Call Participants Chasen Bender - Citi Operator Good day and thank you for standing by. Welcome to the Quarter One Nu Skin Enterprises Earnings Conference Call.

NU Skin Enterprises, Inc. (NUS) Q1 2023 Earnings Call Transcript

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.76 per share a year ago.

Nu Skin Enterprises (NUS) Beats Q1 Earnings and Revenue Estimates

Company Reiterates 2023 Guidance PROVO, Utah , May 3, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced first quarter 2023 results in line with expectations. Executive Summary Q1 2023 vs.

Nu Skin Enterprises Reports First Quarter 2023 Financial Results

Nu Skin's (NUS) first-quarter performance is likely to reflect macro headwinds like prolonged COVID-related disruptions, unfavorable currency rates and global inflation.

Factors to Consider Ahead of Nu Skin's (NUS) Q1 Earnings

Is Nu Skin Enterprises (NUS) Stock Undervalued Right Now?

Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Report highlights the global sustainability and social impact of the beauty and wellness brand  PROVO, Utah , April 19, 2023 /PRNewswire/ -- Nu Skin, a global leader in beauty and wellness, today released its 2022 Social Impact and Sustainability Report. The report outlines progress on the company's environmental, social and governance (ESG) priorities, including its sustainability commitments and global giving efforts.

News for Nu Skin Enterprises Stock (NUS)